EG Corporation (KOSDAQ:037370)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	51,232	49,594	104,448	63,825	111,881	73,200
Market Cap Growth	-35.03%	-52.52%	63.65%	-42.95%	52.84%	13.09%
Enterprise Value	120,367	119,525	171,923	121,452	161,129	118,050
Last Close Price	5940.00	5750.00	12110.00	7400.00	13500.00	9760.00
PE Ratio	-	-	-	-	23.38	-
PS Ratio	0.79	0.76	1.69	0.91	1.17	1.63
PB Ratio	2.12	1.85	3.16	1.26	1.91	1.94
P/TBV Ratio	0.93	0.88	1.77	1.00	1.79	1.73
P/OCF Ratio	-	-	-	-	-	135.55
EV/Sales Ratio	1.87	1.83	2.78	1.73	1.68	2.62
EV/EBITDA Ratio	-	-	-	-	22.36	-
EV/EBIT Ratio	-	-	-	-	28.05	-
EV/FCF Ratio	-34.34	-	-	-	-	-
Debt / Equity Ratio	4.40	3.94	2.99	1.66	1.14	1.64
Debt / EBITDA Ratio	-	-	-	-	9.28	-
Asset Turnover	0.44	0.43	0.41	0.47	0.72	0.45
Inventory Turnover	15.75	17.61	15.03	20.69	37.13	20.60
Quick Ratio	0.12	0.13	0.38	0.92	1.37	0.47
Current Ratio	0.15	0.16	0.63	1.52	1.65	0.70
Return on Equity (ROE)	-15.76%	-22.57%	-49.18%	-20.63%	8.81%	-18.96%
Return on Assets (ROA)	-2.00%	-2.40%	-5.91%	-3.75%	2.69%	-4.43%
Return on Capital (ROIC)	-2.29%	-2.74%	-6.73%	-4.32%	3.19%	-5.44%
Return on Capital Employed (ROCE)	-	-	-	-	4.70%	-
Earnings Yield	-0.11%	-5.56%	-7.63%	-3.77%	4.28%	-5.61%
FCF Yield	-6.84%	-13.24%	-25.39%	-38.35%	-24.46%	-36.26%
Payout Ratio	-	-	-	-	1.39%	-
Buyback Yield / Dilution	0.00%	-	-1.63%	-10.31%	-2.57%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.